Naiquan Mao

Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial

Dongsheng Yue, Wenxiang Wang, Hongxu Liu et al. · The Lancet Respiratory Medicine · 2024 · 76 citations

Interim Analysis, Surgical Oncology, Neoadjuvant Chemotherapy +12

Cancer-Associated Fibroblasts Accelerate Malignant Progression of Non-Small Cell Lung Cancer via Connexin 43-Formed Unidirectional Gap Junctional Intercellular Communication

Min Luo, Yanmei Luo, Naiquan Mao et al. · Cellular Physiology and Biochemistry · 2018 · 61 citations · Full text

<i>NFE2L2/KEAP1</i> Mutations Correlate with Higher Tumor Mutational Burden Value/PD-L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy

Xian Xu, Yang Yang, Xiaoyan Liu et al. · The Oncologist · 2020 · 56 citations · Full text

Casticin induces caspase-mediated apoptosis via activation of mitochondrial pathway and upregulation of DR5 in human lung cancer cells

Yuan Zhou, Yi Peng, Qiqi Mao et al. · Asian Pacific Journal of Tropical Medicine · 2013 · 36 citations · Full text

Efficient targeted tumor imaging and secreted endostatin gene delivery by anti-CD105 immunoliposomes

Huiqin Zhuo, Baoshi Zheng, Jianming Liu et al. · Journal of Experimental & Clinical Cancer Research · 2018 · 25 citations · Full text